María J Alonso Selected Research

Phenylephrine (Neo-Synephrine)

11/2019	Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway.
1/2016	Spironolactone Prevents Endothelial Nitric Oxide Synthase Uncoupling and Vascular Dysfunction Induced by β-Adrenergic Overstimulation: Role of Perivascular Adipose Tissue.
1/2013	Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension.
12/2008	Ouabain treatment changes the role of endothelial factors in rat resistance arteries.
4/2007	Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.
4/2005	Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses.
11/2002	Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors.
2/2002	Alterations in phenylephrine-induced contractions and the vascular expression of Na+,K+-ATPase in ouabain-induced hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

María J Alonso Research Topics

Disease

27	Hypertension (High Blood Pressure) 01/2021 - 02/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 04/2011
2	Neoplasms (Cancer) 10/2019 - 09/2019
2	Vascular Remodeling 01/2018 - 07/2009
1	Infections 01/2020
1	Fibrosarcoma 10/2019
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Human Influenza (Influenza) 10/2017
1	Sudden Infant Death (SID) 10/2017
1	Corneal Opacity 12/2016
1	Corneal Injuries 12/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Heart Failure 01/2016
1	Myocardial Infarction 01/2016
1	Essential Hypertension 01/2016
1	Inflammation (Inflammations) 05/2014
1	Insulin Resistance 05/2014
1	Obesity 05/2014
1	Vascular Diseases (Vascular Disease) 05/2014
1	Pre-Eclampsia (Preeclampsia) 02/2004

Drug/Important Bio-Agent (IBA)

8	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2019 - 02/2002
7	Ouabain (G Strophanthin)IBA 12/2008 - 02/2002
5	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018 - 01/2013
5	ProstaglandinsIBA 01/2014 - 09/2002
4	NanocapsulesIBA 10/2019 - 12/2016
4	Vasoconstrictor AgentsIBA 01/2016 - 04/2005
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021 - 01/2014
3	Losartan (Cozaar)FDA LinkGeneric 01/2016 - 09/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 01/2013
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2013 - 04/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2008 - 03/2002
2	EnzymesIBA 01/2021 - 09/2004
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2021 - 02/2004
2	CytokinesIBA 01/2021 - 02/2012
2	Peptides (Polypeptides)IBA 01/2020 - 05/2007
2	Pioglitazone (Actos)FDA Link 11/2019 - 06/2014
2	Protamines (Protamine Sulfate)FDA Link 09/2019 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 02/2002
2	Endothelins (Endothelin)IBA 06/2014 - 11/2004
2	AngiotensinsIBA 05/2014 - 11/2004
2	Vasodilator Agents (Vasodilators)IBA 01/2014 - 11/2002
2	Angiotensin IIIBA 01/2014 - 07/2009
2	Superoxides (Superoxide)IBA 01/2014 - 09/2002
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2013 - 02/2003
2	MercuryIBA 01/2013 - 04/2011
1	Carbon MonoxideIBA 01/2021
1	Heme (Haem)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Biliverdine (Biliverdin)IBA 01/2021
1	BilirubinIBA 01/2021
1	AntioxidantsIBA 01/2021
1	NanovaccinesIBA 01/2020
1	Endothelin-1 (Endothelin 1)IBA 11/2019
1	MicroRNAs (MicroRNA)IBA 09/2019
1	CurcuminIBA 09/2019
1	Prostaglandin-E SynthasesIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Sodium CholateIBA 10/2017
1	tocophersolanIBA 10/2017
1	AntigensIBA 10/2017
1	Hemagglutinins (Hemagglutinin)IBA 10/2017
1	Tocopherols (Tocopherol)IBA 10/2017
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2016
1	Vitamin A (Retinol)FDA LinkGeneric 12/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2015
1	rho-Associated KinasesIBA 01/2015
1	ThiazolidinedionesIBA 06/2014
1	ReninIBA 05/2014
1	Insulin (Novolin)FDA Link 05/2014
1	AdipokinesIBA 05/2014
1	AldosteroneIBA 05/2014
1	Advanced Glycation End ProductsIBA 05/2014
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2014
1	Toll-Like Receptor 4IBA 01/2014
1	OxygenasesIBA 01/2014
1	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2013
1	Celecoxib (Celebrex)FDA Link 01/2013
1	acetovanillone (apocynin)IBA 01/2013
1	TEMPOIBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2009
1	Atorvastatin (Lipitor)FDA Link 07/2009
1	Protein Kinase CIBA 05/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	Mangifera indica extractIBA 09/2004
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2004
1	BradykininIBA 07/2004
1	Arginine (L-Arginine)FDA Link 02/2004
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2004
1	Potassium Channels (Potassium Channel)IBA 11/2002
1	CalciumIBA 11/2002
1	LipopolysaccharidesIBA 09/2002
1	AnionsIBA 09/2002

Therapy/Procedure

1	Immunotherapy 10/2019
1	Therapeutics 09/2019
1	Photorefractive Keratectomy 12/2016